Bo Amdi Jensen

493 total citations
12 papers, 127 citations indexed

About

Bo Amdi Jensen is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Bo Amdi Jensen has authored 12 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in Bo Amdi Jensen's work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Viral-associated cancers and disorders (2 papers). Bo Amdi Jensen is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Viral-associated cancers and disorders (2 papers). Bo Amdi Jensen collaborates with scholars based in Denmark, Australia and Switzerland. Bo Amdi Jensen's co-authors include Peter de Nully Brown, Francesco d’Amore, Michael Pedersen, Anne Ortved Gang, Paw Jensen, A Hjortrup, Bente Frølund, Henrik Frederiksen, Madeleine King and Michael Roost Clausen and has published in prestigious journals such as Quality of Life Research, American Journal of Hematology and International Archives of Occupational and Environmental Health.

In The Last Decade

Bo Amdi Jensen

12 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Amdi Jensen Denmark	7	62	40	26	20	16	12	127
Virginia Noxon United States	9	53 0.9×	37 0.9×	14 0.5×	10 0.5×	7 0.4×	31	163
Malek Baassiri United States	6	54 0.9×	51 1.3×	51 2.0×	25 1.3×	16 1.0×	10	234
Michaela Čepelová Czechia	5	64 1.0×	22 0.6×	22 0.8×	29 1.4×	26 1.6×	18	104
Esmée C. de Baat Netherlands	6	15 0.2×	51 1.3×	57 2.2×	8 0.4×	26 1.6×	7	208
Juana María Cano Spain	8	39 0.6×	82 2.0×	40 1.5×	5 0.3×	12 0.8×	25	136
Marta Solans Spain	7	28 0.5×	66 1.6×	34 1.3×	22 1.1×	6 0.4×	14	177
Katell Le Dû France	6	39 0.6×	44 1.1×	40 1.5×	17 0.8×	8 0.5×	20	124
Anna Ratiu United States	4	18 0.3×	33 0.8×	59 2.3×	12 0.6×	28 1.8×	7	174
Anne Jacobsen Germany	8	46 0.7×	163 4.1×	60 2.3×	10 0.5×	8 0.5×	15	246

Countries citing papers authored by Bo Amdi Jensen

Since Specialization

Citations

This map shows the geographic impact of Bo Amdi Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Amdi Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Amdi Jensen more than expected).

Fields of papers citing papers by Bo Amdi Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Amdi Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Amdi Jensen. The network helps show where Bo Amdi Jensen may publish in the future.

Co-authorship network of co-authors of Bo Amdi Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Amdi Jensen. A scholar is included among the top collaborators of Bo Amdi Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Amdi Jensen. Bo Amdi Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lund, Thomas, Annette Juul Vangsted, Carsten Helleberg, et al.. (2024). P-349 Multiple Myeloma Patients Who Are in VGPR or Better Benefits From Continued Treatment With Zoledronic Acid Beyond Two Years. Clinical Lymphoma Myeloma & Leukemia. 24. S234–S235. 2 indexed citations

Nielsen, Lene Kongsgaard, Rebecca Mercieca‐Bebber, Sören Möller, et al.. (2024). Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms. Quality of Life Research. 33(9). 2387–2400. 1 indexed citations

Schjesvold, Fredrik, Annette Juul Vangsted, Carsten Helleberg, et al.. (2023). OA-10 Four years treatment with zoledronic acid is superior to two years in protection against progressive bone disease in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 23. S6–S7. 1 indexed citations

Nielsen, Lene Kongsgaard, Madeleine King, Sören Möller, et al.. (2019). Strategies to improve patient-reported outcome completion rates in longitudinal studies. Quality of Life Research. 29(2). 335–346. 28 indexed citations

Gang, Anne Ortved, Michael Pedersen, Francesco d’Amore, et al.. (2015). A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry. Leukemia & lymphoma. 56(9). 2556–2562. 20 indexed citations

Pedersen, Martin Bjerregård, Stephen Hamilton‐Dutoit, Knud Bendix, et al.. (2014). Evaluation of clinical trial eligibility and prognostic indices in a population‐based cohort of systemic peripheral T‐cell lymphomas from the Danish Lymphoma Registry. Hematological Oncology. 33(4). 120–128. 8 indexed citations

Mylam, Karen Juul, Martin Bøgsted, Peter de Nully Brown, et al.. (2014). Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non‐Hodgkin and Hodgkin lymphoma. American Journal of Hematology. 89(6). 575–580. 37 indexed citations

El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations

Zimakoff, J, Bo Amdi Jensen, Jan Tønnesen, et al.. (2002). [The Good Medical Department. Results from a national survey of quality in 1998].. PubMed. 164(38). 4431–7. 2 indexed citations

10.

Jensen, Bo Amdi, et al.. (1995). Assessment of long-term styrene exposure: a comparative study of a logbook method and biological monitoring. International Archives of Occupational and Environmental Health. 66(6). 399–405. 7 indexed citations

11.

Jensen, Bo Amdi, et al.. (1994). On the Concept of the “Normal” Day: Quality Control of Occupational Hygiene Measurements. Applied Occupational and Environmental Hygiene. 9(4). 245–255. 10 indexed citations

12.

Jensen, Bo Amdi, et al.. (1988). Adrenocortical function in old age as reflected by plasma cortisol and ACTH test during the course of acute myocardial infarction. Archives of Gerontology and Geriatrics. 7(4). 289–296. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact